Oklo
OKLO
$41.70
-8.73%
Oklo Inc. is developing advanced fission power plants, specifically liquid metal fast reactors under the Aurora product line, to provide clean, reliable, and affordable energy at scale, while also pursuing used nuclear fuel recycling services for the U.S. market. As a pre-revenue, pre-commercial nuclear technology company, Oklo is a speculative disruptor in the advanced nuclear energy space, distinct from traditional reactor builders due to its focus on small modular reactors (SMRs) and fuel recycling. The current investor narrative centers on regulatory milestones and DOE program selections that validate its technology, but is tempered by persistent dilution fears, negative cash flows, and a stock that has declined over 50% in the past six months amid market skepticism about its path to commercialization.…
OKLO
Oklo
$41.70
Related headlines
Investment Opinion: Should I buy OKLO Today?
Rating: Hold. Oklo is a speculative pre-revenue nuclear stock with a consensus Buy rating (mean 2.04) and an average target of $86.50, implying 89.3% upside. However, the severe downtrend, accelerating losses, and dilution risk warrant caution. The thesis is that regulatory milestones and DOE validation could catalyze a re-rating, but the lack of near-term revenue makes it a high-risk bet. Supporting evidence: (1) The average analyst target of $86.50 suggests significant upside if commercialization succeeds. (2) The $1.59B cash position provides a multi-year runway. (3) Recent DOE selections and a fuel supply agreement with Centrus Energy validate the technology. (4) The stock is trading near its 52-week low, offering a potential entry point for risk-tolerant investors. However, the zero revenue, expanding losses (-$33.1M in Q1 2026), and 7.1x price-to-book premium to peers are major concerns. Risks: The biggest risk is that the company fails to commercialize, leading to a total loss of equity value. A second risk is further dilution from additional equity offerings. This Hold would upgrade to Buy if the stock breaks above its 50-day moving average (~$55) and shows sustained momentum, or if the company announces a commercial partnership. It would downgrade to Sell if the stock breaks below $44.16 (52-week low) or if cash burn accelerates significantly. Valuation verdict: Oklo is overvalued relative to its fundamentals (zero revenue, negative earnings) but fairly valued relative to its cash position and speculative potential. The 7.1x PB is a premium to peers, but the cash balance provides a floor.
Sign up to view all
OKLO 12-Month Price Forecast
The AI assessment is bearish with medium confidence. The technical downtrend is severe, with the stock losing over half its value in six months and trading near its 52-week low. Fundamentals are weak: no revenue, expanding losses, and reliance on equity financing. The 7.1x price-to-book ratio is expensive relative to peers, and the wide analyst target range ($14-$140) reflects extreme uncertainty. While regulatory milestones could catalyze a recovery, the current momentum and risk profile favor the downside. A stance upgrade to neutral would require the stock to stabilize above $50 and show signs of a trend reversal.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Oklo's 12-month outlook, with a consensus price target around $86.50 and implied upside of +107.4% versus the current price.
Average Target
$86.50
0 analysts
Implied Upside
+107.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$14 - $140
Analyst target range
Oklo is covered by 20 analysts, with a consensus recommendation of 'Buy' (mean score 2.04 on a 1-5 scale, where 1 is Strong Buy). The average target price is $86.50, implying a significant 89.3% upside from the current price of $45.69. The distribution shows 2 Neutral ratings (UBS, Citigroup) and the rest are Buy/Outperform/Overweight, indicating a bullish consensus despite the stock's poor price performance. The implied upside is substantial, but the gap between the current price and the average target suggests analysts believe the market is undervaluing the company's long-term potential. The target price range spans from a low of $14.00 to a high of $140.00, a spread of $126 (900% of the low), indicating extreme uncertainty. The high target of $140 assumes successful commercialization, regulatory approvals, and eventual revenue generation, likely factoring in multiple expansion and growth catalysts. The low target of $14 implies a scenario where the company fails to commercialize, leading to further dilution or bankruptcy, and represents a 69% downside from current levels. Recent ratings actions show no changes in the past month (all reaffirmations), with firms like Wedbush (Outperform), Cantor Fitzgerald (Overweight), and Needham (Buy) maintaining bullish stances. The wide target spread reflects the binary nature of the investment thesis: success could yield massive returns, while failure could lead to total loss. The consensus leans bullish, but the high dispersion signals low conviction in near-term outcomes.
Bulls vs Bears: OKLO Investment Factors
Oklo presents a high-risk, high-reward speculative investment. The bull case rests on massive upside to analyst targets (89% average), a strong cash position, and regulatory validation. However, the bear case is equally compelling: zero revenue, expanding losses, severe stock decline, and dilution risk. The single most important tension is whether Oklo can achieve commercialization before its cash runway runs out or further dilution destroys shareholder value. Currently, the bearish evidence is stronger given the accelerating downtrend and lack of near-term revenue visibility.
Bullish
- Massive Upside to Analyst Targets: The average analyst target price is $86.50, implying 89.3% upside from the current $45.69. The high target of $140 suggests potential 206% upside if commercialization succeeds.
- Strong Cash Position Funds Development: Oklo holds $1.59 billion in cash with zero debt, providing a multi-year runway to fund reactor development and regulatory milestones without near-term financing risk.
- Regulatory and DOE Validation: Recent DOE program selections and a fuel supply agreement with Centrus Energy address critical fuel bottlenecks, validating Oklo's technology and business model.
- Speculative Appeal in Clean Energy: As a pre-revenue advanced nuclear company, Oklo offers a pure-play on next-generation fission, attracting investors seeking high-risk, high-reward exposure to the nuclear renaissance.
Bearish
- Zero Revenue and Expanding Losses: Oklo has no revenue and net losses grew from -$9.8M in Q1 2025 to -$33.1M in Q1 2026, a 238% increase. Operating expenses surged to $51.1M, reflecting accelerating cash burn.
- Severe Stock Price Decline: The stock has fallen 51.9% over six months and 25% over one year, trading near its 52-week low of $44.16. The downtrend is accelerating with 1-month and 3-month losses of -24.8% and -28.8%.
- Dilution Risk from Equity Offerings: A $1.18 billion equity offering in Q1 2026 increased shares outstanding by ~22% from 140M to 170M. Further dilution is likely as the company relies on equity to fund operations.
- Extreme Valuation Uncertainty: With no revenue or earnings, the price-to-book ratio of 7.1x is a 78-137% premium to the industrial machinery average of 3-4x. The wide analyst target range ($14-$140) reflects binary outcomes.
OKLO Technical Analysis
Oklo is in a sustained downtrend, with the stock price declining 25.0% over the past year and currently trading at $45.69, which is just 23.6% of its 52-week range (low $44.16, high $193.84). The price sits near the 52-week low, indicating a deeply bearish posture and suggesting the market is pricing in significant risk or disappointment. The 1-year price change of -25.0% underperforms the S&P 500's +20.9% gain, highlighting persistent relative weakness. Short-term momentum is decisively negative: the 1-month price change is -24.8% and the 3-month change is -28.8%, both accelerating the downtrend from the 1-year decline. This divergence—where short-term losses are steeper than the annual loss—signals a capitulation phase or a potential mean-reversion setup, but the consistent negative momentum across all time frames argues against a near-term reversal. The relative strength versus the S&P 500 is deeply negative across all periods (1-month -25.4%, 3-month -35.1%, 6-month -61.0%), confirming the stock is in a severe relative downtrend. Key support is the 52-week low of $44.16; a break below this level would signal a new leg lower and likely trigger stop-loss selling. Resistance sits at the 52-week high of $193.84, a level that seems distant given current momentum. The stock's beta of 1.159 indicates it is about 16% more volatile than the market, meaning it amplifies market moves—a factor that exacerbates downside risk in a bearish phase. A breakdown below $44.16 could accelerate selling, while a recovery above the recent 50-day moving average (around $55) would be needed to suggest a short-term bottom.
Beta
1.16
1.16x market volatility
Max Drawdown
-76.0%
Largest decline past year
52-Week Range
$41-$194
Price range past year
Annual Return
-35.2%
Cumulative gain past year
| Period | OKLO Return | S&P 500 |
|---|---|---|
| 1m | -27.4% | +0.1% |
| 3m | -37.6% | +5.7% |
| 6m | -56.1% | +8.5% |
| 1y | -35.2% | +20.3% |
| ytd | -46.4% | +10.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
OKLO Fundamental Analysis
Oklo is a pre-revenue company with zero revenue reported in the most recent quarter (Q1 2026) and all prior quarters, reflecting its pre-commercial stage. The company has no revenue trajectory to analyze; instead, the focus is on cash burn and progress toward commercialization. Net income was -$33.1 million in Q1 2026, worsening from -$9.8 million in Q1 2025, indicating that losses are expanding as the company scales its development efforts. The lack of revenue means gross margin is undefined (0%), and operating margin is also 0% as there is no revenue to offset costs. The company is unprofitable with a trailing EPS of -$0.19 and a negative net margin. However, the trajectory of losses is not narrowing—operating expenses (R&D and SG&A) have grown from $17.9 million in Q1 2025 to $51.1 million in Q1 2026, reflecting increased investment in reactor development and regulatory activities. The balance sheet shows a strong liquidity position with $1.59 billion in cash as of Q1 2026, up from $788 million at year-end 2025, following a massive $1.18 billion equity offering in Q1 2026. The debt-to-equity ratio is negligible at 0.001, indicating no debt reliance. However, free cash flow was -$50.7 million in Q1 2026, and trailing twelve-month free cash flow is -$153.5 million, meaning the company is burning cash at an accelerating rate. The current ratio of 49.1 is extremely high due to the large cash balance, but this is a temporary cushion that will erode without revenue. ROE is -7.2%, reflecting negative shareholder returns. The company's ability to fund operations internally is absent; it depends entirely on equity financing, as evidenced by the recent dilutive offering.
Quarterly Revenue
$0.0B
2026-03
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
$-153481000.0B
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is OKLO Overvalued?
Since net income is negative, the price-to-sales (PS) ratio is the primary valuation metric, but Oklo has zero revenue, making the PS ratio undefined (0). Therefore, we use the price-to-book (PB) ratio as the most relevant metric, given the company's asset-light, cash-heavy balance sheet. The trailing PB ratio is 7.1x, based on book value per share of approximately $6.42 (calculated from market cap of $10.5B and shares outstanding of ~170M). This is a premium to the historical PB range; for example, in Q1 2026 the PB was 3.2x, meaning the current multiple has more than doubled. The forward PE is -54.4x, reflecting expectations of continued losses. Compared to the industrial machinery industry average PB of roughly 3-4x (based on typical sector data), Oklo's 7.1x PB represents a 78-137% premium. This premium is not justified by profitability (negative earnings) or revenue (zero), but rather by the market's speculative bet on future commercialization and the large cash pile. Historically, Oklo's PB has ranged from 1.9x (in early 2022) to 150.5x (in late 2021, when book value was very low). The current 7.1x is near the middle of this wide range but elevated relative to the pre-IPO levels. The high PB suggests the market is pricing in optimistic expectations for future asset growth and eventual revenue generation, but the lack of earnings or sales makes this a purely speculative valuation.
PE
-99.7x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-88.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Oklo's primary financial risk is its cash burn rate. With free cash flow of -$50.7M in Q1 2026 and TTM FCF of -$153.5M, the $1.59B cash pile provides a runway of roughly 2.6 years at current burn rates. However, operating expenses grew 186% YoY to $51.1M, indicating the burn is accelerating. The company has no revenue, so it depends entirely on equity financing, as evidenced by the $1.18B dilutive offering in Q1 2026. Further dilution is a material risk for existing shareholders. Market & Competitive Risks: The stock trades at a 7.1x price-to-book ratio, a premium to the industrial machinery average of 3-4x, implying the market is pricing in optimistic future growth. With a beta of 1.159, Oklo amplifies market moves, making it vulnerable to sector rotation away from speculative growth stocks. Competitive risks include other advanced nuclear developers (e.g., NuScale, TerraPower) and regulatory delays. Recent news highlights that persistent inflation is repricing rate-cut odds, which could compress valuations for pre-revenue companies. Worst-Case Scenario: If Oklo fails to secure regulatory approval for its Aurora reactor or cannot commercialize, the stock could fall to the analyst low target of $14.00, representing a 69% decline from the current price of $45.69. This would imply a market cap of ~$2.4B, still above the cash balance, but further dilution could erode value. The 52-week low of $44.16 is only 3.3% below the current price, so a break below that level could trigger a rapid decline toward $14.
FAQ
The key risks are: (1) Commercialization risk: Oklo has no revenue and may never successfully commercialize its Aurora reactor. (2) Dilution risk: The company relies on equity financing, as evidenced by the $1.18B offering in Q1 2026 that increased shares by 22%. (3) Regulatory risk: The NRC must approve the reactor design, and any delays could erode investor confidence. (4) Macro risk: With a beta of 1.159, the stock amplifies market moves, and rising interest rates or a recession could compress speculative valuations. The most severe risk is a total loss of equity if the company fails to commercialize, with the analyst low target of $14 implying a 69% downside from current levels.
The 12-month forecast is highly uncertain, with three scenarios: (1) Bull case (20% probability): Stock reaches $86.50-$140, driven by regulatory approval and commercial agreements. (2) Base case (50% probability): Stock trades between $44.16 and $86.50, reflecting continued progress but no near-term revenue. (3) Bear case (30% probability): Stock falls to $14-$44.16, due to regulatory setbacks or dilution. The base case is most likely, assuming Oklo continues to advance its technology without major disruptions. The average analyst target of $86.50 suggests a potential 89.3% upside, but the wide range ($14-$140) indicates low conviction.
Oklo is overvalued relative to its fundamentals but may be fairly valued relative to its cash position. With zero revenue and negative earnings, the price-to-book ratio of 7.1x is a 78-137% premium to the industrial machinery industry average of 3-4x. Historically, the PB has ranged from 1.9x to 150.5x, so the current level is elevated relative to pre-IPO levels. The market is pricing in optimistic expectations for future commercialization, but the lack of revenue or earnings makes the valuation purely speculative. The $1.59B cash balance provides a floor, but the stock's market cap of $10.5B implies the market is valuing the technology and future potential at ~$8.9B above cash.
Oklo is a high-risk, high-reward speculative investment. The average analyst target of $86.50 implies 89.3% upside from the current price of $45.69, but the stock has fallen 51.9% over six months and trades near its 52-week low. The company has zero revenue, expanding losses (-$33.1M in Q1 2026), and relies on equity financing, which led to a 22% dilution in Q1 2026. For risk-tolerant investors with a long-term horizon, it could be a good buy if they believe in the nuclear renaissance and Oklo's technology. However, conservative investors should avoid it due to the binary outcome risk. The biggest downside is a 69% decline to the analyst low target of $14 if commercialization fails.
Oklo is suitable for long-term investment (5+ years) for high-risk-tolerant investors who believe in the nuclear energy thesis. The company is pre-revenue and pre-commercial, so near-term catalysts are binary and unpredictable. Short-term trading is extremely risky given the stock's 51.9% decline over six months and high volatility (beta 1.159). The stock has no dividend, and its price is driven by sentiment and news flow rather than fundamentals. A minimum holding period of 5 years is recommended to allow time for commercialization. Short-term traders should be prepared for sharp moves, as the stock has shown 28% weekly surges and 22% monthly declines in recent history.